3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine)

C156H130ClF5N40O9 — CID 160815206

IUPAC3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine)
SMILESCC(C)(C)c1ccccc1CNC(=O)c1nc2ccccc2nc1N.CCc1ccccc1CNC(=O)c1nc2ccccc2nc1N.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1F.Cc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Cc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Nc1nc2ccccc2nc1-c1nnc(-c2ccccc2Cl)o1.Nc1nc2ccccc2nc1-c1nnc(-c2ccccc2F)o1.Nc1nc2ccccc2nc1C(=O)NC1CCc2ccccc21.Nc1nc2ccccc2nc1C(=O)NCc1ccccc1C(F)(F)F
InChIInChI=1S/C20H22N4O.C18H16N4O.C18H18N4O.C17H13F3N4O.C17H15FN4O.2C17H13N5O.C16H10ClN5O.C16H10FN5O/c1-20(2,3)14-9-5-4-8-13(14)12-22-19(25)17-18(21)24-16-11-7-6-10-15(16)23-17;19-17-16(20-14-7-3-4-8-15(14)21-17)18(23)22-13-10-9-11-5-1-2-6-12(11)13;1-2-12-7-3-4-8-13(12)11-20-18(23)16-17(19)22-15-10-6-5-9-14(15)21-16;18-17(19,20)11-6-2-1-5-10(11)9-22-16(25)14-15(21)24-13-8-4-3-7-12(13)23-14;1-10-5-4-6-11(14(10)18)9-20-17(23)15-16(19)22-13-8-3-2-7-12(13)21-15;2*1-10-6-2-3-7-11(10)16-21-22-17(23-16)14-15(18)20-13-9-5-4-8-12(13)19-14;2*17-10-6-2-1-5-9(10)15-21-22-16(23-15)13-14(18)20-12-8-4-3-7-11(12)19-13/h4-11H,12H2,1-3H3,(H2,21,24)(H,22,25);1-8,13H,9-10H2,(H2,19,21)(H,22,23);3-10H,2,11H2,1H3,(H2,19,22)(H,20,23);1-8H,9H2,(H2,21,24)(H,22,25);2-8H,9H2,1H3,(H2,19,22)(H,20,23);2*2-9H,1H3,(H2,18,20);2*1-8H,(H2,18,20)
InChIKeySEUUJJOTNLZMPA-UHFFFAOYSA-N
MW2839.47 g/mol
LogP27.65
Rot. Bonds23

About 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine)

3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine) (PubChem CID 160815206) has the molecular formula C156H130ClF5N40O9 and a molecular weight of 2839.47 g/mol. Its IUPAC name is 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine).

Molecular Properties

Compound Name3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine)
PubChem CID160815206
Molecular FormulaC156H130ClF5N40O9
Molecular Weight2839.47 g/mol
Exact Mass2837.06
IUPAC Name3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine)
SMILESCC(C)(C)c1ccccc1CNC(=O)c1nc2ccccc2nc1N.CCc1ccccc1CNC(=O)c1nc2ccccc2nc1N.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1F.Cc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Cc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Nc1nc2ccccc2nc1-c1nnc(-c2ccccc2Cl)o1.Nc1nc2ccccc2nc1-c1nnc(-c2ccccc2F)o1.Nc1nc2ccccc2nc1C(=O)NC1CCc2ccccc21.Nc1nc2ccccc2nc1C(=O)NCc1ccccc1C(F)(F)F
InChIInChI=1S/C20H22N4O.C18H16N4O.C18H18N4O.C17H13F3N4O.C17H15FN4O.2C17H13N5O.C16H10ClN5O.C16H10FN5O/c1-20(2,3)14-9-5-4-8-13(14)12-22-19(25)17-18(21)24-16-11-7-6-10-15(16)23-17;19-17-16(20-14-7-3-4-8-15(14)21-17)18(23)22-13-10-9-11-5-1-2-6-12(11)13;1-2-12-7-3-4-8-13(12)11-20-18(23)16-17(19)22-15-10-6-5-9-14(15)21-16;18-17(19,20)11-6-2-1-5-10(11)9-22-16(25)14-15(21)24-13-8-4-3-7-12(13)23-14;1-10-5-4-6-11(14(10)18)9-20-17(23)15-16(19)22-13-8-3-2-7-12(13)21-15;2*1-10-6-2-3-7-11(10)16-21-22-17(23-16)14-15(18)20-13-9-5-4-8-12(13)19-14;2*17-10-6-2-1-5-9(10)15-21-22-16(23-15)13-14(18)20-12-8-4-3-7-11(12)19-13/h4-11H,12H2,1-3H3,(H2,21,24)(H,22,25);1-8,13H,9-10H2,(H2,19,21)(H,22,23);3-10H,2,11H2,1H3,(H2,19,22)(H,20,23);1-8H,9H2,(H2,21,24)(H,22,25);2-8H,9H2,1H3,(H2,19,22)(H,20,23);2*2-9H,1H3,(H2,18,20);2*1-8H,(H2,18,20)
InChIKeySEUUJJOTNLZMPA-UHFFFAOYSA-N
XLogP27.65
TPSA767.38 Ų
H-Bond Donors14
H-Bond Acceptors44
Rotatable Bonds23
Heavy Atoms211
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002839.47
LogP ≤ 527.65
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1044

Analyze 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-amino-N-[(2-aminophenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-benzyl-6,7-difluoroquinoxaline-2-carboxamide;3-amino-N-[(1S)-2,3-dihydro-1H-inden-1-yl]quinoxaline-2-carboxamide;3-amino-N-[(2-nitrophenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chloro-5-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-methylsulfonylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-nitrophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine
CID 160480168
3-amino-N-[(2-aminophenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-benzyl-6,7-difluoroquinoxaline-2-carboxamide;3-amino-N-[(1S)-2,3-dihydro-1H-inden-1-yl]quinoxaline-2-carboxamide;3-amino-N-[(2-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-nitrophenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chloro-5-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-methylsulfonylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-nitrophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine
CID 160872278
3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine
CID 161010266
3-[5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;1,2-diethyl-3-methylcyclohexane;1,2-dimethylcyclohexa-1,3-diene;tris(1,2-dimethylcyclohexane);bis(3,4-dimethylpentan-2-one);2-(2,4-dimethylpent-1-en-3-yl)cyclohexa-1,3-diene;3-ethyl-1,2-dimethylcyclohexene;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine);3-(5-phenyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpent-1-ene
CID 158471653
3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-chloro-4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine
CID 159685556
2-amino-N-benzylquinoline-3-carboxamide;3-amino-N-[(2-chloro-6-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2,6-dichlorophenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2,6-difluorophenyl)methyl]-6,7-difluoroquinoxaline-2-carboxamide;3-amino-N-[(2,6-difluorophenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(1R)-2,3-dihydro-1H-inden-1-yl]quinoxaline-2-carboxamide;3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide;(NE)-N-[1-(3-aminoquinoxalin-2-yl)ethylidene]hydroxylamine;3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-methylquinoxaline-2-carbonitrile
CID 172973741

Frequently Asked Questions

What is the IUPAC name of 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine)?
The IUPAC name of 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine) (CID 160815206) is 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine).
What is the SMILES notation for 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine)?
The canonical SMILES for 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine) is CC(C)(C)c1ccccc1CNC(=O)c1nc2ccccc2nc1N.CCc1ccccc1CNC(=O)c1nc2ccccc2nc1N.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1F.Cc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Cc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Nc1nc2ccccc2nc1-c1nnc(-c2ccccc2Cl)o1.Nc1nc2ccccc2nc1-c1nnc(-c2ccccc2F)o1.Nc1nc2ccccc2nc1C(=O)NC1CCc2ccccc21.Nc1nc2ccccc2nc1C(=O)NCc1ccccc1C(F)(F)F.
What is the InChIKey of 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine)?
The InChIKey is SEUUJJOTNLZMPA-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H22N4O.C18H16N4O.C18H18N4O.C17H13F3N4O.C17H15FN4O.2C17H13N5O.C16H10ClN5O.C16H10FN5O/c1-20(2,3)14-9-5-4-8-13(14)12-22-19(25)17-18(21)24-16-11-7-6-10-15(16)23-17;19-17-16(20-14-7-3-4-8-15(14)21-17)18(23)22-13-10-9-11-5-1-2-6-12(11)13;1-2-12-7-3-4-8-13(12)11-20-18(23)16-17(19)22-15-10-6-5-9-14(15)21-16;18-17(19,20)11-6-2-1-5-10(11)9-22-16(25)14-15(21)24-13-8-4-3-7-12(13)23-14;1-10-5-4-6-11(14(10)18)9-20-17(23)15-16(19)22-13-8-3-2-7-12(13)21-15;2*1-10-6-2-3-7-11(10)16-21-22-17(23-16)14-15(18)20-13-9-5-4-8-12(13)19-14;2*17-10-6-2-1-5-9(10)15-21-22-16(23-15)13-14(18)20-12-8-4-3-7-11(12)19-13/h4-11H,12H2,1-3H3,(H2,21,24)(H,22,25);1-8,13H,9-10H2,(H2,19,21)(H,22,23);3-10H,2,11H2,1H3,(H2,19,22)(H,20,23);1-8H,9H2,(H2,21,24)(H,22,25);2-8H,9H2,1H3,(H2,19,22)(H,20,23);2*2-9H,1H3,(H2,18,20);2*1-8H,(H2,18,20).
What are the key properties of 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine)?
3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine) has a molecular weight of 2839.47 g/mol, XLogP of 27.65, 23 rotatable bonds, 14 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-N-[(2-tert-butylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(2,3-dihydro-1H-inden-1-yl)quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-fluoro-3-methylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine) is sourced from PubChem (CID 160815206), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).